Insider Notice: 5,097 Cencora (COR) Shares Planned for Sale on 09/18/2025

Rhea-AI Filing Summary

Form 144 notice for proposed sale of securities. The filing reports an intended sale of 5,097 common shares through Fidelity Brokerage Services on 09/18/2025 with an aggregate market value of $1,478,130.00. The document shows total shares outstanding of 193,877,881. Acquisition details list 1,334 shares from restricted stock vesting on 09/30/2023 recorded as compensation, and 3,763 shares from options (granted 11/13/2019) transacted 09/18/2025 for cash. The filing also discloses three prior sales by Robert P. Mauch on 06/18/2025, 07/18/2025 and 08/18/2025 of ~4,968–4,969 shares each with gross proceeds shown. Several identifying fields for the filer and issuer are not provided in the text.

Positive

• Transaction details disclosed: The filing provides specific share counts, dates, broker, and gross proceeds for recent sales.
• Acquisition history provided: Origins of the shares (restricted stock vesting and option-related) and nature of payment are stated.

Negative

• Missing issuer and filer identification in provided text: Key fields such as issuer name and filer CIK/CCC are not present in the content supplied.
• Repeated insider sales: Three prior monthly sales of ~4,968–4,969 shares may be viewed negatively by some investors, though materiality relative to outstanding shares appears limited.

Insights

Securities Analyst

TL;DR: Routine insider sale notice showing modest share sales and clear acquisition origins; disclosure appears complete for transaction details.

The filing records a planned sale of 5,097 common shares valued at $1,478,130 via a broker on 09/18/2025 and documents the acquisition history: restricted stock vesting (1,334 shares) and option exercise/transfer (3,763 shares). The filing also lists three prior monthly disposals by the same individual in June, July and August 2025 with gross proceeds, indicating ongoing scheduled sales rather than a single large divestiture. From a market-impact perspective, the quantities are small relative to the reported 193,877,881 shares outstanding, suggesting limited dilution or immediate market impact based solely on these numbers.

Compliance/Risk Analyst

TL;DR: Disclosure follows Rule 144 format but lacks key identifying issuer/filer fields in the provided text, which raises completeness concerns.

The notice includes required transaction-level detail: class, broker, dates, amounts, provenance of shares and past three months sales with proceeds, and the signature/representation language referencing material nonpublic information. However, the provided content omits explicit issuer name and filer CIK/CCC entries as presented here, which are essential for regulatory traceability. That omission in the supplied text limits verification and cross-referencing against issuer records.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5097	1478130.00	193877881	09/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/30/2023	Restricted Stock Vesting	Issuer			1334	09/30/2023	Compensation
Common	09/18/2025	Options Granted - 11/13/2019	Issuer			3763	09/18/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Robert P. Mauch 1 West First Avenue Conshohocken PA 19428-1800	Common	06/18/2025	4969	1467345.70
Robert P. Mauch 1 West First Avenue Conshohocken PA 19428-1800	Common	07/18/2025	4968	1461138.48
Robert P. Mauch 1 West First Avenue Conshohocken PA 19428-1800	Common	08/18/2025	4968	1458257.04

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares are proposed for sale in the Form 144 for COR?

The filing shows a proposed sale of 5,097 common shares through Fidelity Brokerage Services on 09/18/2025 with an aggregate market value of $1,478,130.00.

How were the shares being sold acquired according to the filing?

The filing lists 1,334 shares from restricted stock vesting on 09/30/2023 (compensation) and 3,763 shares from options (granted 11/13/2019) with a transaction date of 09/18/2025 paid in cash.

Does the filing show recent sales by the same person?

Yes. It discloses three sales by Robert P. Mauch on 06/18/2025, 07/18/2025, and 08/18/2025 of approximately 4,968–4,969 shares each with gross proceeds listed for each sale.

What is the total number of outstanding shares reported in the Form 144?

The filing shows 193,877,881 shares outstanding.

Are there any statements about material nonpublic information in the notice?

Yes. The signature/representation language states the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.